To evaluate the clinical efficacy of the early administration of zofenopril in a group of patients with and without metabolic syndrome (MS+ and MS-) and anterior myocardial infarction enrolled in the Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study.
Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome / Borghi, Claudio; Cicero, Arrigo F G; Ambrosioni, Ettore; Mattioli AV. - In: VASCULAR HEALTH AND RISK MANAGEMENT. - ISSN 1176-6344. - ELETTRONICO. - 4:3(2008), pp. 665-671. [10.2147/vhrm.s2799]
Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome
Mattioli AVMembro del Collaboration Group
2008
Abstract
To evaluate the clinical efficacy of the early administration of zofenopril in a group of patients with and without metabolic syndrome (MS+ and MS-) and anterior myocardial infarction enrolled in the Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
